04/04/2024 3:39 PM | Integra LifeSciences (Filer)
| Form DEF 14A | |
04/04/2024 3:46 PM | Integra LifeSciences (Filer)
| Form ARS | |
03/13/2024 3:29 PM | Integra LifeSciences (Issuer) McBreen Michael J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:29 PM | DAVIS ROBERT T. JR. (Reporting) Integra LifeSciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:30 PM | De Witte Jan (Reporting) Integra LifeSciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:25 PM | Integra LifeSciences (Issuer) Mosebrook Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:26 PM | Integra LifeSciences (Issuer) Singh Harvinder (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/13/2024 3:26 PM | Integra LifeSciences (Issuer) Knight Lea Daniels (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 4:14 PM | Integra LifeSciences (Issuer) Schwartz Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 4:15 PM | Integra LifeSciences (Issuer) McBreen Michael J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 4:16 PM | DAVIS ROBERT T. JR. (Reporting) Integra LifeSciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 4:10 PM | Integra LifeSciences (Issuer) Singh Harvinder (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 4:12 PM | De Witte Jan (Reporting) Integra LifeSciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 4:13 PM | Integra LifeSciences (Issuer) Mosebrook Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 3:22 PM | DAVIS ROBERT T. JR. (Reporting) Integra LifeSciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:53 PM | DAVIS ROBERT T. JR. (Reporting) Integra LifeSciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 5:10 AM | Integra LifeSciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 5:15 AM | Integra LifeSciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 3:43 PM | DAVIS ROBERT T. JR. (Reporting) Integra LifeSciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 3:45 PM | Integra LifeSciences (Issuer) Schwartz Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 3:47 PM | Integra LifeSciences (Issuer) Mosebrook Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 3:49 PM | Integra LifeSciences (Issuer) McBreen Michael J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 2:30 PM | Champlain Investment Partners, LLC (Filed by) Integra LifeSciences (Subject)
| Form SC 13G/A | |
02/09/2024 4:49 PM | Capital Research Global Investors (Filed by) Integra LifeSciences (Subject)
| Form SC 13G | |
02/09/2024 11:05 AM | Integra LifeSciences (Subject) MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
02/09/2024 7:40 AM | Integra LifeSciences (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/19/2024 3:43 PM | De Witte Jan (Reporting) Integra LifeSciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:57 PM | Integra LifeSciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/13/2023 3:45 PM | GRAVES JEFFREY A (Reporting) Integra LifeSciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 3:43 PM | GRAVES JEFFREY A (Reporting) Integra LifeSciences (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/13/2023 3:31 PM | Integra LifeSciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/13/2023 5:30 AM | Integra LifeSciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 3:27 PM | De Witte Jan (Reporting) Integra LifeSciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/25/2023 3:21 PM | Integra LifeSciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/25/2023 5:15 AM | Integra LifeSciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/13/2023 3:25 PM | De Witte Jan (Reporting) Integra LifeSciences (Issuer)
| Form 4/A | |
09/05/2023 3:07 PM | Integra LifeSciences (Issuer) Veillon-Berteloot Chantal (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/05/2023 3:10 PM | Integra LifeSciences (Issuer) Veillon-Berteloot Chantal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 8:15 PM | Integra LifeSciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2023 4:54 PM | Integra LifeSciences (Subject) Mosebrook Jeffrey (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/27/2023 4:17 PM | Integra LifeSciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Trump’s last act as President (Ad) You’ve probably never heard of Executive Order #13972.
Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. |
06/21/2023 3:30 PM | Integra LifeSciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/23/2023 5:30 AM | Integra LifeSciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/16/2023 3:34 PM | BRADLEY KEITH (Reporting) Integra LifeSciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2023 3:45 PM | Integra LifeSciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/16/2023 3:30 PM | Clay Shaundra (Reporting) Integra LifeSciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2023 3:18 PM | Integra LifeSciences (Issuer) SCHADE CHRISTIAN S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |